Price Alert

Exact Sciences Corporatio... (EXAS)

NASDAQ: EXAS · Real-Time Price · USD

53.81

2.40 (4.67%)

At close: Sep 05, 2025, 3:59 PM

53.42

-0.72%

After-hours: Sep 05, 2025, 06:17 PM EDT

Exact Sciences Statistics

Share Statistics

Exact Sciences has 189.32M shares outstanding. The number of shares has increased by 2.09% in one year.

Shares Outstanding	189.32M
Shares Change (YoY)	2.09%
Shares Change (QoQ)	1.55%
Owned by Institutions (%)	97.47%
Shares Floating	186.73M
Failed to Deliver (FTD) Shares	258
FTD / Avg. Volume	0.01%

Short Selling Information

The latest short interest is 9.46M, so 5% of the outstanding shares have been sold short.

Short Interest	9.46M
Short % of Shares Out	5%
Short % of Float	5.71%
Short Ratio (days to cover)	1.85

Valuation Ratios

The PE ratio is -10.06 and the forward PE ratio is 97. Exact Sciences's PEG ratio is -0.03.

PE Ratio	-10.06
Forward PE	97
PS Ratio	3.75
Forward PS	2.9
PB Ratio	4.31
P/FCF Ratio	138.84
PEG Ratio	-0.03

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Exact Sciences.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.15, with a Debt / Equity ratio of 1.15.

Current Ratio	2.15
Quick Ratio	1.92
Debt / Equity	1.15
Debt / EBITDA	-3.49
Debt / FCF	36.95
Interest Coverage	-32.8

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$399.84K
Profits Per Employee	$-149.11K
Employee Count	6,900
Asset Turnover	0.47
Inventory Turnover	5.17

Taxes

Income Tax	-7.3M
Effective Tax Rate	0.7%

Stock Price Statistics

The stock price has increased by -8.97% in the last 52 weeks. The beta is 1.05, so Exact Sciences's price volatility has been higher than the market average.

Beta	1.05
52-Week Price Change	-8.97%
50-Day Moving Average	48.84
200-Day Moving Average	51.41
Relative Strength Index (RSI)	71.11
Average Volume (20 Days)	3,105,833

Income Statement

In the last 12 months, Exact Sciences had revenue of 2.76B and earned -1.03B in profits. Earnings per share was -5.59.

Revenue	2.76B
Gross Profit	1.92B
Operating Income	-1.05B
Net Income	-1.03B
EBITDA	-788.73M
EBIT	-1B
Earnings Per Share (EPS)	-5.59

Full Income Statement

Balance Sheet

The company has 600.89M in cash and 2.75B in debt, giving a net cash position of -2.15B.

Cash & Cash Equivalents	600.89M
Total Debt	2.75B
Net Cash	-2.15B
Retained Earnings	-4.5B
Total Assets	5.8B
Working Capital	985.93M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 210.54M and capital expenditures -135.99M, giving a free cash flow of 74.55M.

Operating Cash Flow	210.54M
Capital Expenditures	-135.99M
Free Cash Flow	74.55M
FCF Per Share	0.4

Full Cash Flow Statement

Margins

Gross margin is 69.55%, with operating and profit margins of -38.01% and -37.29%.

Gross Margin	69.55%
Operating Margin	-38.01%
Pretax Margin	-37.56%
Profit Margin	-37.29%
EBITDA Margin	-28.59%
EBIT Margin	-38.01%
FCF Margin	2.7%

Dividends & Yields

EXAS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for EXAS is $65, which is 20.8% higher than the current price. The consensus rating is "Buy".

Price Target	$65
Price Target Difference	20.8%
Analyst Consensus	Buy
Analyst Count	21

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	0.67
Piotroski F-Score	4